Form 8-K - Current report:
SEC Accession No. 0001654954-19-011702
Filing Date
2019-10-15
Accepted
2019-10-15 06:52:37
Documents
5
Period of Report
2019-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cvm_8k.htm 8-K 29625
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION cvm_ex3c.htm EX-3.C 10659
3 BYLAWS cvm_ex3d.htm EX-3.D 51881
4 2019 NON-QUALIFIED STOCK OPTION PLAN cvm_ex107.htm EX-10.7 30088
5 2019 STOCK COMPENSATION PLAN cvm_ex108.htm EX-10.8 18622
  Complete submission text file 0001654954-19-011702.txt   142068
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 191149058
SIC: 2836 Biological Products, (No Diagnostic Substances)